Q BIOMED INC. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/59858cc6-df26-41a0-a9b6-145fdb6dc2b7/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-2.1M | 2021-12-01 – 2022-11-30 | evidence 0001410578-23-001376 |
| FY 2021 | $-8.2M | 2020-12-01 – 2021-11-30 | evidence 0001410578-22-000230 |
| FY 2020 | $-13.5M | 2019-12-01 – 2020-11-30 | evidence 0001104659-21-029985 |
| FY 2019 | $-10.3M | 2018-12-01 – 2019-11-30 | evidence 0001104659-20-027119 |
| FY 2018 | $-9.3M | 2017-12-01 – 2018-11-30 | evidence 0001144204-19-012723 |
| FY 2017 | $-14.5M | 2016-12-01 – 2017-11-30 | evidence 0001654954-18-001966 |
| FY 2016 | $-7.2M | 2015-12-01 – 2016-11-30 | evidence 0001424884-17-000008 |
| FY 2015 | $-1.1M | 2014-12-01 – 2015-11-30 | evidence 0001424884-16-000219 |
| FY 2014 | $-38.0k | 2013-12-01 – 2014-11-30 | evidence 0001393905-15-000084 |
| FY 2013 | $-500 | 2012-12-01 – 2013-11-30 | evidence 0001393905-15-000084 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).